本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its first revenue results conference call since its public listing. The Group will release its unaudited revenues for the full-year 2022 on Friday, February 17, 2023. On the same day, at 8:00 a.m. Eastern Standard Time (9:00 p.m. China Standard Time), the Group will host a conference call and webcast to discuss the released results and provide an outlook for 2023. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, please visit the "Events" tab of the Group's investor relations website at https://ir.lanvin-group.com. All participants who would like to join the conference call must pre-register using the link provided below. Once the registration is complete, participants will receive dial-in numbers, a passcode, and a registrant ID which can be used to join the conference call. Participants may register at any time, including up to and after the call starts. Registration Link:https://dpregister.com/sreg/10175603/f5e737e150 Additionally, an archived webcast of the conference call will be available on the Group's investor relations website at https://ir.lanvin-group.com. A replay of the conference call will be accessible approximately one hour after the live call until February 24, 2023, by dialing the following numbers: US Toll Free: 1-877-344-7529International Toll: 1-412-317-0088Canada Toll Free: 855-669-9658Replay Access Code: 2215107 About Lanvin Group Lanvin Group is a leading global luxury fashion group headquartered in Shanghai, China, managing iconic brands worldwide including Lanvin, Wolford, Sergio Rossi, St. John Knits, and Caruso. Harnessing the power of its unique strategic alliance of industry-leading partners in the luxury fashion sector, Lanvin Group strives to expand the global footprint of its portfolio brands and achieve sustainable growth through strategic investment and extensive operational know-how, combined with an intimate understanding and unparalleled access to the fastest-growing luxury fashion markets in the world. For more information about Lanvin Group, please visit www.lanvin-group.com, and to view our investor presentation, please visit www.lanvin-group.com/investor-relation/. Enquiries: MediaLanvin GroupFGS Global Richard Barton +852 9301 2056 or +41 79 922 7892 richard.barton@fgsglobal.com Louis Hung +852 9084 1801 louis.hung@fgsglobal.com InvestorsLanvin Groupir@lanvin-group.com
STOCKHOLM, Feb. 10, 2023 /PRNewswire/ -- Fourth quarter Order intake amounted to SEK 2,529 (1,234) million, an increase of 105 percent Net sales increased 16 percent to SEK 1,497 (1,295) million. Based on constant exchange rates, net sales increased 6 percent EBIT amounted to SEK 262 (204) million and the EBIT margin was 18 (16) percent Earnings per share were SEK 2.56 (1.82) January-December Order intake amounted to SEK 6,783 (4,506) million, an increase of 51 percent Net sales increased 10 percent to SEK 5,119 (4,635) million. Based on constant exchange rates, net sales increased 1 percent EBIT amounted to SEK 894 (1,049) million and the EBIT margin was 17 (23) percent Earnings per share were SEK 7.59 (8.48) The Board of Directors proposes a dividend of SEK 3.50 (3.00) per share to the 2023 Annual General Meeting Outlook 2023 It is the Board of Directors' opinion that consolidated net sales for 2023 will be at a level of SEK 5.5 billion. CEO comments The end of the year was characterized by record order intake, which increased 105 percent in the fourth quarter, driven by a fantastic development in Pattern Generators. The order intake resulted in a record order backlog, which provides a solid base for our work going forward. The Group's net sales were also the best ever, after an increase of 16 percent, with Pattern Generators, High Flex and High Volume contributing to the development. EBIT strengthened to SEK 262 million, corresponding to an EBIT margin of 18 percent. Pattern Generators received its first order for an FPS10 Evo in the fourth quarter. This is a new product in the FPS Evo series for writing photomasks to produce Fine Metal Masks, which are used when manufacturing OLED displays. The order intake for the quarter was at record levels and included one Prexision 800 Evo, three Prexision 8 Evos, one Prexision 8 Entry Evo, two Prexision Lite 8 Evos, one FPS10 Evo, one Prexision MMS and six SLXs. Demand in High Flex during the fourth quarter was healthy, particularly in Europe, but also in the US and Mexico, where the division's customers have well-filled order books. The Chinese market was challenging, although the easing of covid restrictions could present opportunities going forward. High Flex established operations in Mexico in the fourth quarter and opened a sales and service center in Guadalajara, that will support both High Flex and High Volume in the future. After covid restrictions in China were lifted at the end of the fourth quarter, High Volume noted a clear increase in project requests from existing customers in consumer electronics, a customer segment that otherwise showed weak demand throughout 2022. Global Technologies' business for electrical tests of printed circuit boards and substrates reported strong aftermarket sales in a specific type of test, where it commands a unique position. In die bonding, the largest markets are data and telecom, which were hesitant during the quarter, as was the Chinese market as a whole. As I look back over the full year 2022, I am happy to conclude that we have been largely successful at producing and delivering to our customers despite being faced with major challenges in terms of shortage of components, logistics and difficulties in recruiting staff. We also succeeded at keeping the gross margins at a healthy level despite rising material costs. The reason that the Group's gross margin nevertheless declined year-on-year was the lower sales and less favorable product mix in Pattern Generators, which we announced already in last year's year-end report. For us important steps were taken in terms of our sustainability work during 2022. However, much remains to be done and we will tirelessly continue our efforts in this area. For 2023, the opinion of the Board of Directors and myself is that Mycronic's net sales will be at a level of SEK 5.5 billion. Anders Lindqvist, President and CEO FINANCIAL INFORMATION Mycronic AB (publ) is listed on Nasdaq Stockholm, Large Cap. The information in this report is published in accordance with the EU Market Abuse Regulation and the Swedish Securities Act. The information was submitted for publication through the contact persons stated below on February 10, 2023 at 08:00 a.m. CET. Financial reports and press releases are published in Swedish and English and are available on www.mycronic.com. This report was not reviewed by the company's auditor. CONFERENCE CALL Mycronic will hold a teleconference at 10:00 a.m. CET on February 10, 2023, with President and CEO Anders Lindqvist and CFO and Sr VP Corporate Development Pierre Brorsson. To participate, please dial one of the numbers or watch via the web link below. Sweden: +46 8 505 100 31UK: +44 207 107 0613United States: +1 631 570 5613Link to webcast FOR ADDITIONAL INFORMATION, PLEASE CONTACT Anders LindqvistPresident and CEOTel: +46 8 638 52 00E-mail: anders.lindqvist@mycronic.com Pierre BrorssonCFO & Sr VP Corporate Development Tel: +46 8 638 52 00E-mail: pierre.brorsson@mycronic.com Sven ChetkovichDirector Investor RelationsTel: +46 70 558 39 19E-mail: sven.chetkovich@mycronic.com The following files are available for download: https://mb.cision.com/Main/10432/3711833/1837640.pdf Full report (PDF)
RIYADH, Saudi Arabia, Feb. 8, 2023 /PRNewswire/ -- The 2nd Edition of the Financial Sector Conference (FSC 2023) organized by the Financial Sector Development Program partners (Ministry of Finance, Saudi Central Bank, and Capital Market Authority) will be held March 15-16, 2023 at the King Abdulaziz International Conference Center in Riyadh. It will be attended by decision-makers in the financial sector and senior executives in local, regional, and international financial institutions, as well as international investors, entrepreneurs, and prominent academics. Saudi Arabia to Launch 2nd Edition of Financial Sector Conference (FSC) March 15-16, 2023 in Riyadh FSC 2023 will build on the objectives of the first edition in 2019, which sought integration between the financial sector ecosystem with its various means and tools, contributing to continuous growth within a framework of robust and solid fiscal stability, while employing innovative tools in the development and management of services. The FSC 2023 agenda includes a discussion of the key topics regarding the aspirations and concerns of the financial community. Participants will discuss the challenges and opportunities facing the global economy, supply chain constraints, a changing world order, the protracted pandemic, and other factors causing slow growth in many regions worldwide that affect the financial sector and its ecosystem. The conference will explore the extent to which financial institutions are resilient and coping with the new financial landscape, which is characterized by rapid technology development, more emerging non-banking institutions, new economic realities, and changing demand. These aspects require the financial institutions to revisit their roles in the market, as well as the way they flexibly serve their clients to enhance their positions in the market. Participants will discuss investing for tomorrow, which requires reviews of risk management strategies and product offerings, green investment/financing, new assets, new technology, and changing investor expectations. Participants will also address increasing interest rates, market fluctuations, and other new challenges and opportunities that aim to achieve safe investments for tomorrow. The conference will conclude with extensive discussions about the future of the financial sector in light of digitization. For those whom are interested to attend the conference, please register through the link https://registration.fsc.sa/ CONTACT:Khaled Al Qareshahk.alqareshah@mof.gov.sa+966 50 449 5744
HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 7, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced that the Company's subsidiary, RNAimmune, Inc. ("RNAimmune"), has been accepted for oral presentation at the American Association for Cancer Research ("AACR") Annual Meeting 2023. The AACR Annual Meeting will take place April 14–19, 2023 in Orlando, Florida, the United States. RNAimmune is a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines. Presentation Details Presentation Session Category:Experimental and Molecular Therapeutics Presentation Title:A pan-ras mRNA vaccine elicits specific immune responses and inhibits tumor growth in the mouse model of colon cancer Presentation Session Title:New Tricks for Known Targets: Novel Approaches to Inhibit Oncogenic Signaling Presenter:Dong Shen, M.D., PhD, Founder and President of RNAimmune Date/Time:Tuesday, April 18, 2023, 2:30 p.m. – 4:30 p.m. EST Presentation Venue:Orange County Convention Center, Orlando, Florida, the United States (The presentation will also be published in the online proceedings of the AACR.) RNAimmune will present a pre-clinical study showing the latest progress of mRNA cancer vaccine. The study shows that immunization of the mRNA vaccine can elicit T and B cell responses, which are crucial in anti-cancer immunotherapy, and inhibit tumor growth in the mouse model of colon cancer, prolonging survival. Notably, the anti-tumor effect is further enhanced in the combination of anti-PD1 antibody. RAS is one of the most common mutated oncogenes in human cancer. Unfortunately, there is still a lack of specifically effective medication for most RAS-mutated cancer patients. For G12C-mutated patients, drug resistance frequently appears soon after targeted therapy. The reported Pan RAS mRNA cancer vaccine was designed and screened by RNAimmune, which owns its proprietary independent intellectual property rights. Its antitumor effects have been validated both in vitro and in vivo. The current program yielded outstanding antitumor activity, and RNAimmune plans to submit to the U.S. Food and Drug Administration an Investigational New Drug application after completion of the current dose titration study. About AACR Found in 1907, AACR is the first and largest cancer research organization dedicated to fighting against cancer. The annual meeting of AACR is one of the biggest meetings in the global cancer research community, and it highlights the latest advances in anti-cancer research and development from all over the world. About RNAimmune RNAimmune is an international biopharmaceutical company focusing on mRNA vaccine and therapeutics development. Its global headquarter is in Germantown, Maryland, USA, while the China headquarter is located in International BioIsland, Guangzhou. RNAimmune has received a global exclusive right to the proprietary Polypeptide Lipid Nanoparticle (PLNP) technology for mRNA delivery from Sirnaomics. In addition, RNAimmune has various independent proprietary R&D platforms, including artificial-intelligence and directed neoantigen prediction, ALEPVA algorithm for nucleic acid sequence design and lipid nanoparticle (LNP) carrier systems. RNAimmune also deployed various vaccines and therapeutics pipelines, including vaccines for infectious diseases (Covid-19, influenza, VZV and RSV et.) and cancer vaccines (RAS, NY-ESO-1), and protein replacement medication. RNAimmune has extremely high potential and has become one of the leading companies in the field of mRNA vaccines and therapeutics. Learn more at www.rnaimmune.com. About Sirnaomics Sirnaomics is an RNA therapeutics biopharmaceutical group with product candidates in preclinical and clinical stages that focuses on the discovery and development of innovative drugs for indications with medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics group to have a strong presence in both China and the United States, and also the first group of companies to achieve positive Phase IIa clinical outcomes in oncology for an RNAi therapeutics for its core product, STP705. Learn more at www.sirnaomics.com.
BEIJING, Feb. 7, 2023 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video and game business group, will report its fourth quarter and fiscal year 2022 unaudited financial results on Tuesday, February 21, 2023, before U.S. market hours. Sohu's management team will host a conference call on the same day at 7:30 a.m. U.S. Eastern Time, February 21, 2023 (8:30 p.m. Beijing/Hong Kong time, February 21, 2023) following the quarterly results announcement. Conference Call Preregistration Participants can register for the conference call by click here, you will be led to the conference registration website. Upon registration, each participant will receive details for the conference call, including dial-in numbers and a unique access PIN. Please dial in 10 minutes before the call is scheduled to begin. The live webcast and archive of the conference call will be available on the Investor Relations section of Sohu's website at https://investors.sohu.com/. About Sohu.com Sohu.com Limited (NASDAQ: SOHU) was established by Dr. Charles Zhang, one of China's internet pioneers, in the 1990s. As a mainstream media platform in China, Sohu is indispensable to the daily life of millions of Chinese, providing a network of web properties and community based products which continually offer a broad array of choices regarding information, entertainment and communication to the vast number of Sohu users. Sohu has built one of the most comprehensive matrices of Chinese language web properties, consisting of the leading online media destinations Sohu News App, mobile news portal m.sohu.com, PC portal www.sohu.com; online video website tv.sohu.com; and the online games platform www.changyou.com/en/. Sohu provides online brand advertising services as well as multiple news, information and content services on its matrix of websites and also on its mobile platforms. Sohu's online game business, conducted by its subsidiary Changyou, develops and operates a diverse portfolio of PC and mobile games, such as Tian Long Ba Bu ("TLBB"), one of the most popular PC games in China. For investor and media inquiries, please contact: In China: Ms. Pu Huang Sohu.com Limited Tel: +86 (10) 6272-6645 E-mail: ir@contact.sohu.com In the United States: Ms. Linda Bergkamp Christensen Tel: +1 (480) 614-3004 E-mail: linda.bergkamp@christensencomms.com
SHANGHAI, Feb. 6, 2023 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it plans to release its unaudited financial results for the fourth quarter of 2022 before the U.S. market opens on Monday, February 13, 2023. The Company's management will hold an earnings conference call at 8:00 A.M. Eastern Time on Monday, February 13, 2023 (9:00 P.M. Beijing Time on the same day) to discuss the financial results. The presentation and question and answer session will be presented in both Mandarin and English. Listeners may access the call by dialing the following numbers: International: United States Toll Free: Mainland China Toll Free: Hong Kong Toll Free: Conference ID: 1-412-317-60611-888-317-60034001-206115800-9639766437553 The replay will be accessible through February 20, 2023 by dialing the following numbers: International: United States: Access Code: 1-412-317-00881-877-344-75298634168 A live and archived webcast of the conference call will also be available at the Company's investor relations website at https://ir.100.me. About Dingdong (Cayman) Limited Dingdong is the leading fresh grocery e-commerce company in China, with sustainable long-term growth. The Company directly provides users and households with fresh produce, prepared food, and other food products through a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. Leveraging its deep insights into consumers' evolving needs and its strong food innovation capabilities, Dingdong has successfully launched a series of private label products spanning a variety of food categories. Many of Dingdong's private label products are produced at its own production plants, allowing it to more efficiently produce and offer safe and high-quality food products. Dingdong aims to be Chinese families' first choice for food shopping. For more information, please visit: https://ir.100.me. For investor inquiries, please contact:Dingdong Freshir@100.me
A12 藝術空間
Conference call announcements
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
